Berkshire Buys the Dip on UnitedHealth Group Stock. Should You?
Buffett & Co. picked up UnitedHealth stock on the cheap, with the embattled blue chip one of the newest holdings in the Berkshire Hathaway equity portfolio.
UnitedHealth Group (UNH) is soaring out of the gate Friday after regulatory filings revealed Warren Buffett's holding company, Berkshire Hathaway (BRK.B), initiated a stake in the beaten-down Dow Jones stock in the second quarter.
According to WhaleWisdom, Warren Buffett's holding company bought a little more than 5 million UNH shares between April 1 and June 30, accounting for 0.6% of the Berkshire Hathaway equity portfolio and making it the 18th-largest position.
The stake was worth a market value of $1.6 billion at the end of Q2.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Why did Buffett buy UnitedHealth stock?
It's been a rough stretch for UnitedHealth – both on and off the price charts. The country's largest health insurer has struggled with rising Medicare costs and a Department of Justice investigation into its billing practices.
The company also announced in May that its CEO, Andrew Witty, was stepping down. And in July, it gave a full-year outlook that came in well below what Wall Street was expecting.
"When we prepared our 2025 Medicare Advantage offerings back in the first half of 2024, we significantly underestimated the accelerating medical trend and did not modify benefits or plan offerings sufficiently to offset the pressures we are now experiencing," said UnitedHealthcare CEO Tim Noel on the company's earnings call.
And its share price has plummeted as a result. In the past 12 months, UNH shares have plunged 52%. And they're down 46% for the year to date through April 14 – making UnitedHealth the worst Dow Jones stock of 2025 so far.
And this may explain why UnitedHealth was one of the stocks Buffett bought in Q2. Following its recent slump, UNH's forward price-to-earnings (P/E) ratio is now at 16.5 – below both its five-year average of 19.2, according to Morningstar, and the S&P 500's forward P/E ratio of 23.3.
And if there's one thing Warren Buffett loves, it's a bargain. Also working in UnitedHealth's favor is its fat 3.3% dividend yield, which, at the moment, is more than double the yield on the S&P 500.
Does this make UNH stock a buy?
Buffett & Co. are not the only ones on Wall Street that have signaled their confidence in the embattled blue chip stock.
Of the 26 analysts covering UnitedHealth Group who are tracked by S&P Global Market Intelligence, 13 say it's a Strong Buy, six call it a Buy, five have it at Hold and two rate it a Strong Sell. This works out to a consensus Buy recommendation.
Meanwhile, the average price target of $327.29 represents implied upside of more than 20% over the next 12 months or so. And the Street's loftiest target price on UNH of $626 is more than two times higher than the stock's current price.
Truist Securities analyst David MacDonald is one of those with a Buy rating on UNH.
"The company has several initiatives underway to drive improvement across segments," MacDonald wrote in a July 31 note, adding that he sees "opportunity around value-based care and broader margin improvement aided by further leveraging [of] automation/AI over time."
The analyst adds that "long-term execution" is key and that UnitedHealth Group's cash flow "should help drive balanced ongoing capital deployment while supporting corrective actions and investment in core capabilities and technology/efficiency."
Related content
- The Best Value Stocks to Buy
- What Set Warren Buffett Apart
- 5 of Warren Buffett's Best Investments
- 7 of Warren Buffett's Biggest Misses
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at a local investment research firm. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
The Top 10 Side Gigs For Retirees In 2026Money is freedom in retirement; here’s how to earn more of it with a profitable side gig
-
3 Retirement Changes to Watch in 2026: Tax EditionRetirement Taxes Between the Social Security "senior bonus" phaseout and changes to Roth tax rules, your 2026 retirement plan may need an update. Here's what to know.
-
The 'Yes, And...' Rule for RetirementRetirement rarely follows the script. That’s why the best retirees learn to improvise.
-
What Not to Do After Inheriting Wealth: 4 Mistakes That Could Cost You EverythingGen X and Millennials are expected to receive trillions of dollars in inheritance. Unless it's managed properly, the money could slip through their fingers.
-
'The Money Prism' Solves Retirement Money's Biggest Headache: Here's HowThis simple, three-zone system (Blue for bills, Green for paycheck, Red for growth) helps you organize your retirement savings by purpose and time.
-
No, AI Can't Plan Your Retirement: This (Human) Investment Adviser Explains WhyAI has infinite uses. But creating an accurate retirement strategy based on your unique goals is one place where its possibilities seem lacking.
-
A Value Focus Clips Returns for This Mairs & Power Growth FundRough years for UnitedHealth and Fiserv have weighed on returns for one of our favorite mutual funds.
-
Small-Cap Stocks Gain Momentum. That's Good News for This iShares ETFThe clouds appear to be parting for small-cap stocks, which bodes well for one of our favorite exchange-traded funds.
-
Don't Let a 60/40 Portfolio Derail Your Retirement: Why a Cookie-Cutter Approach Could Cost YouChoosing a personalized retirement investment plan, rather than relying on the 60/40 portfolio, could help protect your savings and ensure long-term growth.
-
Are You Winging Your Retirement Plan? A Wealth Adviser's Tips to Help Build Wealth and Navigate RiskIf you have no strategy tying together your accounts or haven't modeled scenarios to make sure your savings will last, then your plan is probably inefficient.
-
Divide and Conquer: Your Annual Financial Plan Made Easy, Courtesy of a Financial AdviserOverwhelmed by your financial to-do list? Split it into four quarters and assign each one goals that connect to the time of year. It could be life-changing.